KETOROLAC TROMETHAMINE

KETOROLAC TROMETHAMINE was reported 5080 times

KETOROLAC TROMETHAMINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TRACHEAL DEVIATION 15 0.1705
1 PERIUMBILICAL ABSCESS 5 0.0746
2 PHRENIC NERVE PARALYSIS 15 0.0685
3 CORNEAL THINNING 15 0.0584
4 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 30 0.0574
5 ASYMPTOMATIC BACTERIURIA 6 0.0441
6 CORNEAL EPITHELIUM DEFECT 24 0.0413
7 CHEMICAL EYE INJURY 4 0.0408
8 RENAL ISCHAEMIA 22 0.0402
9 IRIDOCELE 5 0.0385
10 CHILD ABUSE 9 0.0347
11 CATHETER SITE ABSCESS 6 0.0345
12 PUNCTATE KERATITIS 30 0.0327
13 VICTIM OF CHILD ABUSE 8 0.0319
14 BURNING FEET SYNDROME 8 0.0319
15 PURPURA FULMINANS 8 0.0315
16 RETINAL PIGMENT EPITHELIOPATHY 12 0.0278
17 CORNEAL SCAR 13 0.0258
18 ULCERATIVE KERATITIS 70 0.0255
19 BRONCHIAL HYPERREACTIVITY 30 0.0249
20 MONOCYTOSIS 15 0.0242
21 ANTERIOR CHAMBER CELL 17 0.0238
22 EPIDURAL LIPOMATOSIS 8 0.0233
23 COLD URTICARIA 5 0.0227
24 PULMONARY FUNCTION TEST ABNORMAL 30 0.0192
25 SYMBLEPHARON 5 0.0192
26 CORNEAL DYSTROPHY 7 0.0167
27 VAGINAL LESION 5 0.0163
28 CORNEAL OEDEMA 30 0.0134
29 PRODUCT CLOSURE REMOVAL DIFFICULT 13 0.0127
30 CORNEAL INFILTRATES 4 0.0127
31 CORNEAL PERFORATION 8 0.0127
32 TONGUE PARALYSIS 9 0.0126
33 NASAL DISCOMFORT 98 0.0123
34 INTRAOCULAR LENS IMPLANT 6 0.0121
35 TOXIC ANTERIOR SEGMENT SYNDROME 13 0.0119
36 CORNEAL ABRASION 16 0.0117
37 CORNEAL DISORDER 24 0.0109
38 ISCHAEMIC CARDIOMYOPATHY 33 0.0108
39 CORNEAL OPACITY 14 0.0102
40 HYPERTENSIVE URGENCY 5 0.0090
41 EXPOSURE TO SARS-COV-2 15 0.0088
42 CHONDROLYSIS 4 0.0085
43 LEUKOCYTURIA 7 0.0085
44 RENAL INFARCT 12 0.0083
45 PANCREATIC PSEUDOCYST 6 0.0077
46 NASAL CRUSTING 5 0.0077
47 EROSIVE DUODENITIS 6 0.0075
48 CORNEAL EROSION 4 0.0074
49 BREATH SOUNDS ABNORMAL 33 0.0067
50 SUPERFICIAL INJURY OF EYE 7 0.0064
51 SACROILIITIS 12 0.0064
52 INFUSION SITE DISCHARGE 11 0.0063
53 PANCREATITIS RELAPSING 5 0.0061
54 RENAL TUBULAR INJURY 7 0.0058
55 VASOCONSTRICTION 5 0.0057
56 CORNEAL TRANSPLANT 4 0.0051
57 NASAL DISORDER 13 0.0049
58 NOROVIRUS INFECTION 7 0.0048
59 DYSENTERY 9 0.0048
60 BILIARY DYSKINESIA 8 0.0047
61 BILIARY OBSTRUCTION 6 0.0046
62 INFUSION SITE BRUISING 10 0.0046
63 ATROPHY 9 0.0046
64 KERATITIS 14 0.0046
65 EYELID PAIN 9 0.0044
66 KERATOPATHY 7 0.0044
67 EYE INFLAMMATION 42 0.0044
68 NASAL ULCER 7 0.0044
69 FOREIGN BODY SENSATION IN EYES 28 0.0044
70 INTERVERTEBRAL DISCITIS 8 0.0042
71 COLONIC POLYP 7 0.0042
72 PRODUCT PACKAGING DIFFICULT TO OPEN 11 0.0042
73 NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL 6 0.0041
74 ABDOMINAL MASS 11 0.0041
75 POOR QUALITY DRUG ADMINISTERED 25 0.0039
76 PRODUCT CONTAINER ISSUE 33 0.0038
77 GASTROINTESTINAL VIRAL INFECTION 4 0.0038
78 EYE PAIN 217 0.0038
79 MACULAR OEDEMA 21 0.0037
80 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 5 0.0037
81 EYE OEDEMA 9 0.0037
82 VITREOUS HAEMORRHAGE 10 0.0036
83 PANCREATITIS CHRONIC 8 0.0034
84 CONJUNCTIVITIS ALLERGIC 5 0.0034
85 CHOLECYSTITIS CHRONIC 22 0.0033
86 ESSENTIAL HYPERTENSION 6 0.0033
87 JUVENILE IDIOPATHIC ARTHRITIS 8 0.0033
88 METAMORPHOPSIA 6 0.0033
89 RESPIRATORY RATE DECREASED 10 0.0032
90 OBSTRUCTIVE AIRWAYS DISORDER 35 0.0031
91 PANCREATIC CYST 6 0.0031
92 INTRAOCULAR PRESSURE INCREASED 40 0.0031
93 EYE IRRITATION 180 0.0031
94 GALLBLADDER INJURY 6 0.0031
95 INFUSION SITE SWELLING 19 0.0030
96 EYE INJURY 9 0.0030
97 RHINALGIA 8 0.0029
98 CHEST INJURY 6 0.0029
99 PRODUCT PACKAGING CONFUSION 7 0.0029
100 NECROTISING FASCIITIS 10 0.0028
101 CONJUNCTIVAL HYPERAEMIA 10 0.0028
102 HYPERPARATHYROIDISM SECONDARY 7 0.0028
103 PERIORBITAL OEDEMA 14 0.0027
104 HYPERTENSIVE HEART DISEASE 5 0.0027
105 CYSTOID MACULAR OEDEMA 5 0.0027
106 CARDIOMYOPATHY 39 0.0026
107 RETINAL OEDEMA 5 0.0026
108 FIBROSIS 8 0.0026
109 NEPHROGENIC ANAEMIA 12 0.0026
110 TREATMENT FAILURE 213 0.0026
111 INFUSION SITE PRURITUS 8 0.0025
112 RESPIRATORY DEPRESSION 31 0.0025
113 ENDOPHTHALMITIS 15 0.0025
114 COSTOCHONDRITIS 4 0.0025
115 HEPATIC NEOPLASM 8 0.0024
116 INFUSION SITE HAEMORRHAGE 8 0.0024
117 COMPULSIVE SHOPPING 5 0.0024
118 MULTIPLE ALLERGIES 19 0.0024
119 INFUSION SITE PAIN 31 0.0024
120 BODY TEMPERATURE FLUCTUATION 5 0.0024
121 DILATATION VENTRICULAR 5 0.0024
122 CATARACT OPERATION 14 0.0024
123 INCORRECT DRUG ADMINISTRATION RATE 10 0.0023
124 OCULAR DISCOMFORT 26 0.0023
125 BLOOD CHLORIDE INCREASED 4 0.0023
126 TENDERNESS 24 0.0023
127 SNEEZING 51 0.0023
128 MENINGITIS ASEPTIC 10 0.0022
129 DIABETIC NEUROPATHY 11 0.0022
130 COMPUTERISED TOMOGRAM ABNORMAL 5 0.0022
131 DUODENAL ULCER 15 0.0021
132 SINUS OPERATION 5 0.0021
133 SCOLIOSIS 13 0.0021
134 HAEMOTHORAX 6 0.0021
135 CONVERSION DISORDER 4 0.0021
136 CAROTID ARTERY STENOSIS 7 0.0020
137 CENTRAL VENOUS CATHETERISATION 6 0.0020
138 DIVERTICULUM 14 0.0020
139 BLOOD PRESSURE DIASTOLIC ABNORMAL 5 0.0020
140 CATARACT 116 0.0019
141 VISUAL ACUITY REDUCED 64 0.0019
142 PHOTOPHOBIA 36 0.0019
143 EOSINOPHILIA 33 0.0019
144 PRODUCT DELIVERY MECHANISM ISSUE 10 0.0019
145 PARANASAL SINUS DISCOMFORT 7 0.0018
146 LACRIMATION INCREASED 55 0.0018
147 PLEURITIC PAIN 5 0.0018
148 PEPTIC ULCER 6 0.0018
149 GASTROINTESTINAL ULCER 4 0.0018
150 ECONOMIC PROBLEM 27 0.0018
151 INFUSION SITE ERYTHEMA 15 0.0018
152 PERIORBITAL SWELLING 10 0.0018
153 OBSTRUCTION 7 0.0018
154 EYELID MARGIN CRUSTING 5 0.0017
155 BILIARY COLIC 5 0.0017
156 STRIDOR 5 0.0017
157 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 12 0.0017
158 SEASONAL ALLERGY 23 0.0016
159 OCULAR HYPERAEMIA 76 0.0016
160 FLANK PAIN 15 0.0016
161 SARS-COV-2 TEST POSITIVE 21 0.0016
162 ORTHOPNOEA 5 0.0016
163 AORTIC ARTERIOSCLEROSIS 4 0.0016
164 CATHETER SITE PAIN 4 0.0015
165 SPINAL PAIN 18 0.0015
166 OEDEMA MOUTH 5 0.0015
167 RENAL TUBULAR NECROSIS 15 0.0015
168 GALLBLADDER DISORDER 27 0.0015
169 HIGH DENSITY LIPOPROTEIN DECREASED 5 0.0015
170 BLEPHARITIS 6 0.0015
171 PERIPHERAL ISCHAEMIA 6 0.0015
172 POST PROCEDURAL COMPLICATION 28 0.0015
173 NASAL DRYNESS 9 0.0014
174 EYE DISORDER 47 0.0014
175 PULMONARY ALVEOLAR HAEMORRHAGE 8 0.0014
176 VITREOUS FLOATERS 14 0.0014
177 STAPHYLOCOCCAL SEPSIS 7 0.0014
178 INFLAMMATORY MARKER INCREASED 7 0.0014
179 INTERVERTEBRAL DISC DEGENERATION 13 0.0014
180 LEFT VENTRICULAR HYPERTROPHY 6 0.0014
181 PRODUCT ADMINISTRATION INTERRUPTED 11 0.0014
182 EYE SWELLING 52 0.0014
183 ABNORMAL SENSATION IN EYE 6 0.0014
184 SPINAL OSTEOARTHRITIS 12 0.0014
185 PERIPHERAL VASCULAR DISORDER 7 0.0014
186 POOR VENOUS ACCESS 14 0.0014
187 EYE DISCHARGE 14 0.0013
188 ATELECTASIS 13 0.0013
189 RENAL FAILURE ACUTE 57 0.0013
190 OSTEOMYELITIS 24 0.0013
191 MIGRAINE 125 0.0013
192 CHEST X-RAY ABNORMAL 4 0.0013
193 DUODENITIS 4 0.0013
194 EYE OPERATION 6 0.0013
195 BRONCHITIS 96 0.0013
196 FAMILY STRESS 4 0.0013
197 OLIGURIA 8 0.0013
198 NEPHROLITHIASIS 59 0.0013
199 INFUSION SITE EXTRAVASATION 8 0.0013
200 SPINAL CORD COMPRESSION 5 0.0013
201 PROSTATOMEGALY 5 0.0013
202 SINUS TACHYCARDIA 18 0.0013
203 ANAPHYLACTIC REACTION 70 0.0013
204 RENAL CYST 10 0.0013
205 TRICUSPID VALVE INCOMPETENCE 10 0.0013
206 PRODUCT LEAKAGE 7 0.0012
207 ARTERIOSPASM CORONARY 5 0.0012
208 HIATUS HERNIA 16 0.0012
209 CHOLECYSTITIS ACUTE 7 0.0012
210 DERMATITIS CONTACT 14 0.0012
211 BLOOD PRESSURE DIASTOLIC DECREASED 9 0.0012
212 PHARYNGITIS STREPTOCOCCAL 13 0.0012
213 GLAUCOMA 23 0.0012
214 DYSLIPIDAEMIA 6 0.0012
215 UVEITIS 16 0.0012
216 SINUS HEADACHE 7 0.0012
217 INSURANCE ISSUE 18 0.0012
218 POOR PERIPHERAL CIRCULATION 5 0.0012
219 HEPATIC PAIN 5 0.0012
220 PURULENT DISCHARGE 5 0.0012
221 ARTERIOSCLEROSIS 11 0.0012
222 ATRIOVENTRICULAR BLOCK FIRST DEGREE 5 0.0012
223 OCULAR ICTERUS 5 0.0012
224 EYE INFECTION 13 0.0012
225 DRUG PRESCRIBING ERROR 22 0.0011
226 MENISCUS INJURY 7 0.0011
227 ANKYLOSING SPONDYLITIS 15 0.0011
228 GINGIVAL SWELLING 5 0.0011
229 PHYSICAL DISABILITY 5 0.0011
230 FACE OEDEMA 19 0.0011
231 FACIAL PAIN 10 0.0011
232 GASTRIC ULCER 21 0.0011
233 GASTRITIS 29 0.0011
234 IMPAIRED GASTRIC EMPTYING 15 0.0011
235 HYPERAESTHESIA 9 0.0011
236 CHOLECYSTITIS 13 0.0011
237 ANGIOEDEMA 48 0.0011
238 VISION BLURRED 148 0.0011
239 BLOOD PRESSURE SYSTOLIC INCREASED 21 0.0011
240 GASTRITIS EROSIVE 5 0.0011
241 YELLOW SKIN 5 0.0011
242 SPINAL DISORDER 10 0.0011
243 OSTEOPENIA 16 0.0011
244 PULSE ABSENT 5 0.0011
245 BRONCHOSPASM 15 0.0011
246 CARDIAC VALVE DISEASE 6 0.0010
247 POST-TRAUMATIC STRESS DISORDER 7 0.0010
248 RENAL FAILURE CHRONIC 8 0.0010
249 CHOLELITHIASIS 34 0.0010
250 IMPAIRED HEALING 34 0.0010
251 RALES 6 0.0010
252 PRODUCT LABEL ISSUE 7 0.0010
253 SEDATION 27 0.0010
254 TACHYPNOEA 14 0.0010
255 PRODUCT LABEL CONFUSION 6 0.0010
256 TUBULOINTERSTITIAL NEPHRITIS 19 0.0010
257 ROTATOR CUFF SYNDROME 13 0.0010
258 HYPERLIPIDAEMIA 12 0.0010
259 AZOTAEMIA 4 0.0010
260 OBSESSIVE-COMPULSIVE DISORDER 8 0.0010
261 MIOSIS 8 0.0010
262 GANGRENE 6 0.0010
263 FUNGAL SKIN INFECTION 4 0.0010
264 HAND FRACTURE 7 0.0010
265 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 5 0.0010
266 MULTI-ORGAN FAILURE 17 0.0010
267 SINUSITIS 100 0.0010
268 LARYNGEAL OEDEMA 6 0.0010
269 MITRAL VALVE INCOMPETENCE 11 0.0010
270 VENTRICULAR TACHYCARDIA 16 0.0010
271 KIDNEY INFECTION 19 0.0010
272 CHOLECYSTECTOMY 11 0.0010
273 CONGESTIVE CARDIOMYOPATHY 4 0.0010
274 MAJOR DEPRESSION 7 0.0010
275 SWELLING OF EYELID 6 0.0010
276 MULTIPLE INJURIES 6 0.0010
277 EYELID OEDEMA 11 0.0009
278 RECALLED PRODUCT ADMINISTERED 9 0.0009
279 BUNDLE BRANCH BLOCK LEFT 4 0.0009
280 RESPIRATORY ARREST 26 0.0009
281 OBESITY 15 0.0009
282 PANCREATITIS ACUTE 21 0.0009
283 EXPIRED PRODUCT ADMINISTERED 31 0.0009
284 HEREDITARY ANGIOEDEMA 10 0.0009
285 GINGIVITIS 5 0.0009
286 CARDIAC MURMUR 8 0.0009
287 AORTIC ANEURYSM 7 0.0009
288 OESOPHAGITIS 10 0.0009
289 WOUND INFECTION 10 0.0009
290 FAECALOMA 5 0.0009
291 CARDIOMEGALY 11 0.0009
292 EATING DISORDER 19 0.0009
293 COLITIS ISCHAEMIC 6 0.0009
294 POSTOPERATIVE WOUND INFECTION 6 0.0009
295 SINUS CONGESTION 12 0.0009
296 ABDOMINAL HERNIA 4 0.0009
297 EXOSTOSIS 8 0.0009
298 PULMONARY MASS 13 0.0009
299 VISUAL DISTURBANCE 5 0.0009
300 BUNDLE BRANCH BLOCK RIGHT 4 0.0009
301 JOINT EFFUSION 6 0.0009
302 INTERVERTEBRAL DISC PROTRUSION 19 0.0009
303 GASTRIC HAEMORRHAGE 10 0.0009
304 VENTRICULAR EXTRASYSTOLES 9 0.0009
305 BLOOD PRESSURE DIASTOLIC INCREASED 4 0.0009
306 FRUSTRATION TOLERANCE DECREASED 7 0.0009
307 HYPERVENTILATION 5 0.0009
308 STRESS CARDIOMYOPATHY 5 0.0009
309 POST PROCEDURAL HAEMORRHAGE 10 0.0009
310 MYDRIASIS 11 0.0009
311 BLINDNESS UNILATERAL 12 0.0008
312 UPPER-AIRWAY COUGH SYNDROME 7 0.0008
313 RESPIRATORY TRACT INFECTION 22 0.0008
314 COLITIS MICROSCOPIC 4 0.0008
315 PLEURISY 5 0.0008
316 DRY EYE 42 0.0008
317 ENDOMETRIOSIS 4 0.0008
318 ANHEDONIA 22 0.0008
319 EYE PRURITUS 28 0.0008
320 BLOOD PRESSURE FLUCTUATION 20 0.0008
321 GASTROENTERITIS VIRAL 15 0.0008
322 HAEMATEMESIS 21 0.0008
323 SQUAMOUS CELL CARCINOMA OF SKIN 5 0.0008
324 BACK INJURY 9 0.0008
325 FLUID OVERLOAD 12 0.0008
326 EYE HAEMORRHAGE 11 0.0008
327 END STAGE RENAL DISEASE 15 0.0008
328 BLINDNESS TRANSIENT 6 0.0008
329 LIGAMENT SPRAIN 8 0.0008
330 HYSTERECTOMY 7 0.0008
331 BLOOD PRESSURE ABNORMAL 16 0.0008
332 BURNING SENSATION 56 0.0008
333 INJURY 56 0.0008
334 PHOTOPSIA 5 0.0008
335 EAR INFECTION 21 0.0008
336 TOOTH ABSCESS 8 0.0008
337 GENERALISED TONIC-CLONIC SEIZURE 13 0.0008
338 PRESYNCOPE 19 0.0008
339 FEMORAL NECK FRACTURE 4 0.0008
340 ACUTE RESPIRATORY FAILURE 15 0.0008
341 BLOOD UREA INCREASED 13 0.0008
342 LOW DENSITY LIPOPROTEIN INCREASED 6 0.0008
343 DYSTONIA 15 0.0008
344 MELAENA 17 0.0008
345 ASTHMA 87 0.0008
346 TORSADE DE POINTES 6 0.0008
347 RASH PAPULAR 17 0.0008
348 CLOSTRIDIUM DIFFICILE COLITIS 8 0.0008
349 DIARRHOEA HAEMORRHAGIC 7 0.0007
350 MENINGITIS 5 0.0007
351 LEFT VENTRICULAR DYSFUNCTION 5 0.0007
352 JOINT RANGE OF MOTION DECREASED 10 0.0007
353 SENSORY LOSS 6 0.0007
354 RHINITIS 6 0.0007
355 RHINORRHOEA 48 0.0007
356 HEART RATE DECREASED 26 0.0007
357 FIBROMYALGIA 18 0.0007
358 ERYTHEMA OF EYELID 4 0.0007
359 THROAT IRRITATION 33 0.0007
360 NECK PAIN 41 0.0007
361 EYE MOVEMENT DISORDER 5 0.0007
362 HAEMATURIA 25 0.0007
363 ESCHERICHIA INFECTION 6 0.0007
364 ASTHENOPIA 4 0.0007
365 CORONARY ARTERY DISEASE 22 0.0007
366 HYPERCHOLESTEROLAEMIA 7 0.0007
367 GOUT 13 0.0007
368 ILEUS 9 0.0007
369 DIZZINESS POSTURAL 7 0.0007
370 VENTRICULAR FIBRILLATION 8 0.0007
371 COORDINATION ABNORMAL 10 0.0007
372 DRUG ADMINISTRATION ERROR 22 0.0007
373 EXTRASYSTOLES 5 0.0007
374 CARDIAC DISORDER 67 0.0007
375 PRODUCT PRESCRIBING ERROR 17 0.0007
376 ACUTE PULMONARY OEDEMA 4 0.0007
377 MUSCULOSKELETAL CHEST PAIN 11 0.0007
378 DEVICE OCCLUSION 10 0.0007
379 TENDONITIS 11 0.0007
380 CHEST PAIN 131 0.0007
381 HAEMATOCRIT DECREASED 14 0.0007
382 DRUG INTOLERANCE 68 0.0007
383 LOCALISED INFECTION 17 0.0007
384 BLOOD POTASSIUM DECREASED 21 0.0007
385 CHRONIC KIDNEY DISEASE 53 0.0007
386 BLOOD MAGNESIUM DECREASED 6 0.0007
387 EXERCISE TOLERANCE DECREASED 4 0.0007
388 CELLULITIS 35 0.0007
389 MUSCLE STRAIN 6 0.0007
390 PRODUCT ADMINISTRATION ERROR 14 0.0007
391 UPPER RESPIRATORY TRACT INFECTION 32 0.0007
392 ULCER 11 0.0007
393 SCIATICA 11 0.0007
394 URINE OUTPUT DECREASED 6 0.0007
395 DIVERTICULITIS 19 0.0007
396 OSTEOARTHRITIS 29 0.0007
397 OEDEMA 37 0.0007
398 DIABETES MELLITUS INADEQUATE CONTROL 12 0.0007
399 HYPOPHOSPHATAEMIA 5 0.0007
400 CEREBRAL DISORDER 5 0.0007
401 BACTERAEMIA 8 0.0007
402 EAR PAIN 13 0.0007
403 HYDRONEPHROSIS 5 0.0007
404 CHROMATURIA 15 0.0007
405 GASTROINTESTINAL HAEMORRHAGE 55 0.0007
406 HYPOTHYROIDISM 21 0.0007
407 BODY HEIGHT DECREASED 7 0.0007
408 RECTAL HAEMORRHAGE 28 0.0007
409 PHARYNGEAL OEDEMA 10 0.0006
410 MENTAL STATUS CHANGES 18 0.0006
411 FOOD ALLERGY 5 0.0006
412 PRODUCT DISTRIBUTION ISSUE 6 0.0006
413 ANKLE FRACTURE 10 0.0006
414 AGRANULOCYTOSIS 12 0.0006
415 HAEMOPTYSIS 18 0.0006
416 BIPOLAR DISORDER 7 0.0006
417 BLOOD CREATININE INCREASED 42 0.0006
418 DIABETES MELLITUS 49 0.0006
419 SWOLLEN TONGUE 20 0.0006
420 RENAL INJURY 19 0.0006
421 ASPIRATION 7 0.0006
422 CYANOSIS 10 0.0006
423 CONTUSION 61 0.0006
424 BRAIN OEDEMA 8 0.0006
425 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 33 0.0006
426 FOOT DEFORMITY 7 0.0006
427 NASAL CONGESTION 37 0.0006
428 NERVE INJURY 7 0.0006
429 VISUAL IMPAIRMENT 78 0.0006
430 GINGIVAL PAIN 5 0.0006
431 SUPRAVENTRICULAR TACHYCARDIA 6 0.0006
432 SINUS BRADYCARDIA 6 0.0006
433 CARDIAC FLUTTER 4 0.0006
434 PARKINSONISM 6 0.0006
435 DECUBITUS ULCER 5 0.0006
436 PHARYNGEAL SWELLING 6 0.0006
437 RETCHING 13 0.0006
438 BODY TEMPERATURE DECREASED 6 0.0006
439 INCORRECT PRODUCT STORAGE 8 0.0006
440 DYSGRAPHIA 4 0.0006
441 PERICARDIAL EFFUSION 14 0.0006
442 BONE DISORDER 11 0.0006
443 APPETITE DISORDER 4 0.0006
444 ACUTE KIDNEY INJURY 92 0.0006
445 HYPOXIA 21 0.0006
446 BREAST MASS 4 0.0006
447 BACK PAIN 138 0.0006
448 CONJUNCTIVITIS 11 0.0006
449 DISCOMFORT 36 0.0006
450 BLINDNESS 24 0.0006
451 OXYGEN SATURATION DECREASED 33 0.0006
452 MACULAR DEGENERATION 7 0.0006
453 GINGIVAL BLEEDING 8 0.0006
454 TACHYCARDIA 52 0.0006
455 BRADYCARDIA 31 0.0006
456 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 6 0.0006
457 ECCHYMOSIS 4 0.0006
458 PSEUDOMONAS INFECTION 5 0.0006
459 SKIN HYPERPIGMENTATION 5 0.0006
460 ENCEPHALITIS 4 0.0006
461 NIGHTMARE 20 0.0006
462 BURSITIS 7 0.0006
463 BASAL CELL CARCINOMA 9 0.0006
464 WHEEZING 34 0.0006
465 MASS 8 0.0006
466 CARPAL TUNNEL SYNDROME 8 0.0006
467 VIRAL INFECTION 19 0.0006
468 FUNGAL INFECTION 19 0.0006
469 HEAD INJURY 18 0.0006
470 DISSEMINATED INTRAVASCULAR COAGULATION 8 0.0006
471 DRUG INTERACTION 90 0.0006
472 LUNG INFILTRATION 5 0.0006
473 PHARYNGITIS 7 0.0006
474 CYST 7 0.0006
475 BONE PAIN 33 0.0006
476 INFLAMMATION 29 0.0006
477 FEAR OF INJECTION 4 0.0006
478 OEDEMA PERIPHERAL 68 0.0006
479 MEDICATION ERROR 31 0.0006
480 FEAR 15 0.0006
481 POOR QUALITY SLEEP 12 0.0006
482 DECREASED ACTIVITY 6 0.0006
483 ACTIVITIES OF DAILY LIVING IMPAIRED 11 0.0006
484 THROAT TIGHTNESS 15 0.0006
485 ABDOMINAL PAIN LOWER 14 0.0006
486 BACK DISORDER 9 0.0006
487 COMPLICATION ASSOCIATED WITH DEVICE 8 0.0006
488 LOSS OF CONSCIOUSNESS 70 0.0005
489 PHOTOSENSITIVITY REACTION 9 0.0005
490 PNEUMONIA BACTERIAL 5 0.0005
491 RETINAL DETACHMENT 5 0.0005
492 RASH ERYTHEMATOUS 26 0.0005
493 URTICARIA 91 0.0005
494 UNRESPONSIVE TO STIMULI 14 0.0005
495 DENTAL CARIES 6 0.0005
496 SKIN ULCER 14 0.0005
497 URINARY TRACT INFECTION 92 0.0005
498 DUODENAL ULCER PERFORATION 4 0.0005
499 HEPATIC STEATOSIS 10 0.0005
500 MALNUTRITION 6 0.0005
501 UPPER GASTROINTESTINAL HAEMORRHAGE 9 0.0005
502 SKIN INFECTION 6 0.0005
503 NEPHROPATHY TOXIC 6 0.0005
504 INTESTINAL PERFORATION 6 0.0005
505 CANDIDA INFECTION 9 0.0005
506 BEDRIDDEN 7 0.0005
507 LACERATION 5 0.0005
508 TOOTH INFECTION 7 0.0005
509 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 9 0.0005
510 PANCREATITIS 28 0.0005
511 PAIN IN JAW 15 0.0005
512 PRODUCT PACKAGING ISSUE 5 0.0005
513 SCAB 6 0.0005
514 SCAR 9 0.0005
515 MICTURITION URGENCY 6 0.0005
516 SLEEP APNOEA SYNDROME 10 0.0005
517 PRODUCTIVE COUGH 25 0.0005
518 LOWER LIMB FRACTURE 10 0.0005
519 PRODUCT DOSE OMISSION ISSUE 153 0.0005
520 RENAL FAILURE 69 0.0005
521 EMOTIONAL DISORDER 16 0.0005
522 MADAROSIS 6 0.0005
523 CONCUSSION 4 0.0005
524 ELECTROLYTE IMBALANCE 6 0.0005
525 LIVER FUNCTION TEST ABNORMAL 15 0.0005
526 PULMONARY EMBOLISM 49 0.0005
527 EJECTION FRACTION DECREASED 8 0.0005
528 HYPOAESTHESIA 77 0.0005
529 THERAPY PARTIAL RESPONDER 8 0.0005
530 HAEMORRHOIDS 10 0.0005
531 ELECTROCARDIOGRAM ABNORMAL 4 0.0005
532 AFFECTIVE DISORDER 4 0.0005
533 HYPOPHAGIA 13 0.0005
534 ABDOMINAL DISTENSION 53 0.0005
535 DRUG SCREEN POSITIVE 4 0.0005
536 BLOOD IRON DECREASED 6 0.0005
537 TYPE 2 DIABETES MELLITUS 17 0.0005
538 SINUS DISORDER 10 0.0005
539 BLOOD ALBUMIN DECREASED 4 0.0005
540 RESPIRATORY TRACT CONGESTION 8 0.0005
541 BLADDER DISORDER 5 0.0005
542 RESPIRATORY DISORDER 15 0.0005
543 SKIN DISCOLOURATION 23 0.0005
544 ANXIETY 142 0.0005
545 CHEST DISCOMFORT 51 0.0005
546 LEUKOCYTOSIS 9 0.0005
547 APHASIA 15 0.0005
548 WHITE BLOOD CELL COUNT INCREASED 19 0.0005
549 EPISTAXIS 37 0.0005
550 RASH MACULO-PAPULAR 11 0.0005
551 ABDOMINAL PAIN 115 0.0005
552 NOCTURIA 6 0.0005
553 NEURALGIA 12 0.0005
554 HYPOTENSION 99 0.0005
555 PRODUCT QUALITY ISSUE 67 0.0005
556 DEEP VEIN THROMBOSIS 32 0.0005
557 EYELID PTOSIS 5 0.0005
558 INTERNATIONAL NORMALISED RATIO INCREASED 14 0.0005
559 DYSURIA 18 0.0005
560 MUSCLE SPASTICITY 6 0.0005
561 SMALL INTESTINAL OBSTRUCTION 6 0.0005
562 SPINAL OPERATION 6 0.0005
563 OSTEOPOROSIS 20 0.0005
564 STAPHYLOCOCCAL INFECTION 16 0.0005
565 TEMPERATURE INTOLERANCE 5 0.0005
566 PRODUCT AVAILABILITY ISSUE 11 0.0005
567 BACTERIAL INFECTION 9 0.0005
568 BLOOD BILIRUBIN INCREASED 13 0.0005
569 DRUG ABUSE 40 0.0005
570 PETECHIAE 5 0.0005
571 SECRETION DISCHARGE 6 0.0005
572 DYSPNOEA EXERTIONAL 18 0.0005
573 SWELLING FACE 31 0.0005
574 KNEE ARTHROPLASTY 10 0.0005
575 FOOT FRACTURE 9 0.0005
576 SCRATCH 5 0.0005
577 CARDIAC ARREST 39 0.0005
578 CYSTITIS 15 0.0005
579 HEADACHE 295 0.0005
580 HYPERTENSION 99 0.0005
581 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 8 0.0005
582 HIP FRACTURE 15 0.0005
583 ANAPHYLACTIC SHOCK 12 0.0005
584 MUSCULOSKELETAL DISCOMFORT 8 0.0005
585 ANURIA 4 0.0005
586 PAIN 285 0.0005
587 BLISTER 26 0.0005
588 PLEURAL EFFUSION 28 0.0005
589 ORTHOSTATIC HYPOTENSION 8 0.0005
590 HYPERHIDROSIS 59 0.0005
591 JOINT STIFFNESS 12 0.0005
592 NEUROTOXICITY 8 0.0005
593 BLOOD CALCIUM INCREASED 4 0.0005
594 DYSPNOEA 258 0.0005
595 HYPOKALAEMIA 21 0.0005
596 TOOTH FRACTURE 5 0.0005
597 HYPERSOMNIA 13 0.0005
598 NEUROPATHY PERIPHERAL 43 0.0005
599 LIP SWELLING 15 0.0004
600 STEVENS-JOHNSON SYNDROME 10 0.0004
601 COGNITIVE DISORDER 21 0.0004
602 SPINAL FRACTURE 9 0.0004
603 BRAIN FOG 7 0.0004
604 BLOOD CALCIUM DECREASED 5 0.0004
605 DRUG INEFFECTIVE 586 0.0004
606 OSTEONECROSIS OF JAW 11 0.0004
607 PRODUCT USE COMPLAINT 7 0.0004
608 TASTE DISORDER 9 0.0004
609 EXTRAPYRAMIDAL DISORDER 11 0.0004
610 ABDOMINAL PAIN UPPER 91 0.0004
611 TOOTHACHE 8 0.0004
612 IMPAIRED DRIVING ABILITY 5 0.0004
613 FEBRILE NEUTROPENIA 29 0.0004
614 CARDIAC FAILURE CONGESTIVE 35 0.0004
615 PROSTATIC SPECIFIC ANTIGEN INCREASED 6 0.0004
616 FLUID RETENTION 22 0.0004
617 ARTHRITIS 34 0.0004
618 MUSCLE TIGHTNESS 7 0.0004
619 BLOOD PRESSURE INCREASED 66 0.0004
620 ANAEMIA 82 0.0004
621 HEPATITIS 11 0.0004
622 RASH MACULAR 15 0.0004
623 BALANCE DISORDER 37 0.0004
624 DEFORMITY 4 0.0004
625 SURGERY 25 0.0004
626 OSTEONECROSIS 14 0.0004
627 RESPIRATORY FAILURE 31 0.0004
628 RASH PRURITIC 23 0.0004
629 PULMONARY OEDEMA 19 0.0004
630 FEELING HOT 26 0.0004
631 COVID-19 PNEUMONIA 5 0.0004
632 DIALYSIS 6 0.0004
633 GASTROOESOPHAGEAL REFLUX DISEASE 34 0.0004
634 JOINT INJURY 9 0.0004
635 PROTEINURIA 8 0.0004
636 PNEUMONIA 136 0.0004
637 COMA 20 0.0004
638 SYNCOPE 42 0.0004
639 CHILLS 49 0.0004
640 IMPAIRED QUALITY OF LIFE 6 0.0004
641 COVID-19 73 0.0004
642 TRANSIENT ISCHAEMIC ATTACK 14 0.0004
643 INFECTION 60 0.0004
644 ARTHROPATHY 23 0.0004
645 SEPTIC SHOCK 18 0.0004
646 MUSCULAR WEAKNESS 47 0.0004
647 PRESCRIBED OVERDOSE 8 0.0004
648 VOMITING 194 0.0004
649 HAEMORRHAGE 43 0.0004
650 VERTIGO 25 0.0004
651 CHOKING 8 0.0004
652 NO THERAPEUTIC RESPONSE 5 0.0004
653 FALL 136 0.0004
654 ACUTE MYOCARDIAL INFARCTION 12 0.0004
655 GLOMERULAR FILTRATION RATE DECREASED 5 0.0004
656 LABORATORY TEST ABNORMAL 12 0.0004
657 CARDIO-RESPIRATORY ARREST 17 0.0004
658 COUGH 114 0.0004
659 SKIN HAEMORRHAGE 6 0.0004
660 EMOTIONAL DISTRESS 49 0.0004
661 TOOTH DISORDER 9 0.0004
662 DEPRESSION 92 0.0004
663 DEVICE DEFECTIVE 7 0.0004
664 ERYTHEMA 83 0.0004
665 UPPER LIMB FRACTURE 8 0.0004
666 HAEMORRHAGE INTRACRANIAL 6 0.0004
667 SPEECH DISORDER 21 0.0004
668 PAIN IN EXTREMITY 118 0.0004
669 DYSPHAGIA 38 0.0004
670 HYPERKALAEMIA 14 0.0004
671 HEART RATE IRREGULAR 9 0.0004
672 ILLNESS 41 0.0004
673 BLOOD TRIGLYCERIDES INCREASED 7 0.0004
674 BLOOD GLUCOSE DECREASED 19 0.0004
675 FEEDING DISORDER 8 0.0004
676 PARAESTHESIA 62 0.0004
677 DYSKINESIA 16 0.0004
678 INFUSION RELATED REACTION 26 0.0004
679 BODY TEMPERATURE INCREASED 8 0.0004
680 TINNITUS 18 0.0004
681 BLOOD PRESSURE DECREASED 26 0.0004
682 TARDIVE DYSKINESIA 11 0.0004
683 EAR DISCOMFORT 4 0.0004
684 INTENTIONAL PRODUCT USE ISSUE 34 0.0004
685 NODULE 5 0.0004
686 NAUSEA 303 0.0004
687 ROAD TRAFFIC ACCIDENT 16 0.0004
688 MUSCULOSKELETAL PAIN 20 0.0004
689 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 77 0.0004
690 PULMONARY CONGESTION 5 0.0004
691 BLOOD GLUCOSE ABNORMAL 7 0.0004
692 GASTRIC DISORDER 13 0.0004
693 DISORIENTATION 15 0.0004
694 HYPERSENSITIVITY 70 0.0004
695 DYSGEUSIA 28 0.0004
696 GAIT DISTURBANCE 72 0.0004
697 METABOLIC ACIDOSIS 12 0.0004
698 DIABETIC KETOACIDOSIS 9 0.0004
699 IRRITABLE BOWEL SYNDROME 8 0.0004
700 DYSARTHRIA 14 0.0004
701 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 67 0.0004
702 JAUNDICE 10 0.0004
703 SKIN CANCER 8 0.0004
704 HAEMOGLOBIN DECREASED 38 0.0004
705 HYPOCALCAEMIA 7 0.0004
706 CEREBRAL INFARCTION 9 0.0004
707 LIMB INJURY 10 0.0004
708 LYMPHADENOPATHY 13 0.0004
709 ACUTE HEPATIC FAILURE 5 0.0004
710 METASTASES TO BONE 6 0.0004
711 PERIPHERAL COLDNESS 5 0.0004
712 NERVOUSNESS 19 0.0004
713 SEIZURE 42 0.0004
714 GASTROINTESTINAL PAIN 4 0.0004
715 PERIPHERAL SWELLING 56 0.0004
716 BLOOD ALKALINE PHOSPHATASE INCREASED 9 0.0004
717 RESPIRATORY DISTRESS 10 0.0004
718 PYREXIA 125 0.0004
719 PROCEDURAL PAIN 10 0.0004
720 ATRIAL FIBRILLATION 35 0.0004
721 FEELING COLD 10 0.0004
722 SEPSIS 40 0.0004
723 ORAL HERPES 7 0.0004
724 SKIN FISSURES 7 0.0004
725 PANCYTOPENIA 20 0.0004
726 HYPERGLYCAEMIA 13 0.0004
727 PRODUCT USE ISSUE 67 0.0004
728 OROPHARYNGEAL PAIN 33 0.0004
729 DYSPEPSIA 35 0.0004
730 MUSCULOSKELETAL STIFFNESS 31 0.0004
731 AMNESIA 23 0.0004
732 HYPOGLYCAEMIA 17 0.0004
733 CONVULSION 20 0.0003
734 MUSCLE SPASMS 64 0.0003
735 PRURITUS 134 0.0003
736 THROMBOSIS 28 0.0003
737 FULL BLOOD COUNT DECREASED 7 0.0003
738 HAEMATOMA 9 0.0003
739 MUSCLE TWITCHING 8 0.0003
740 DIPLOPIA 9 0.0003
741 HYPOKINESIA 5 0.0003
742 PALPITATIONS 40 0.0003
743 DERMATITIS ATOPIC 18 0.0003
744 MYALGIA 58 0.0003
745 RIB FRACTURE 7 0.0003
746 HEAD DISCOMFORT 6 0.0003
747 PULMONARY HYPERTENSION 7 0.0003
748 FATIGUE 261 0.0003
749 SOMNOLENCE 67 0.0003
750 HALLUCINATION 25 0.0003
751 RESTLESS LEGS SYNDROME 6 0.0003
752 DEHYDRATION 44 0.0003
753 ARTHRALGIA 137 0.0003
754 GAIT INABILITY 11 0.0003
755 DEVICE FAILURE 5 0.0003
756 CYTOPENIA 4 0.0003
757 LUNG DISORDER 16 0.0003
758 LIVER FUNCTION TEST INCREASED 7 0.0003
759 ENCEPHALOPATHY 8 0.0003
760 FEELING ABNORMAL 78 0.0003
761 DEVICE RELATED INFECTION 5 0.0003
762 DIZZINESS 162 0.0003
763 LIMB DISCOMFORT 10 0.0003
764 INCORRECT PRODUCT ADMINISTRATION DURATION 7 0.0003
765 FAECES DISCOLOURED 7 0.0003
766 BLOOD CHOLESTEROL INCREASED 15 0.0003
767 RENAL IMPAIRMENT 27 0.0003
768 EXTRA DOSE ADMINISTERED 13 0.0003
769 HYPONATRAEMIA 18 0.0003
770 HEPATIC CIRRHOSIS 6 0.0003
771 BLOOD URINE PRESENT 6 0.0003
772 BLOOD LACTATE DEHYDROGENASE INCREASED 5 0.0003
773 PNEUMOTHORAX 5 0.0003
774 WEIGHT DECREASED 88 0.0003
775 ANGINA PECTORIS 9 0.0003
776 ABSCESS 5 0.0003
777 LETHARGY 18 0.0003
778 RASH 136 0.0003
779 THERAPY NON-RESPONDER 14 0.0003
780 BLOOD POTASSIUM INCREASED 5 0.0003
781 CONSTIPATION 67 0.0003
782 PRODUCT USE IN UNAPPROVED INDICATION 76 0.0003
783 ASTHENIA 115 0.0003
784 MUCOSAL INFLAMMATION 8 0.0003
785 INFLUENZA 34 0.0003
786 DISABILITY 6 0.0003
787 HEART RATE INCREASED 30 0.0003
788 DRUG LEVEL INCREASED 5 0.0003
789 GASTROINTESTINAL DISORDER 27 0.0003
790 INSOMNIA 80 0.0003
791 COAGULOPATHY 5 0.0003
792 ABDOMINAL DISCOMFORT 50 0.0003
793 SUICIDE ATTEMPT 18 0.0003
794 DRUG TOXICITY 4 0.0003
795 HOT FLUSH 22 0.0003
796 DYSPHONIA 17 0.0003
797 THERAPEUTIC PRODUCT EFFECT DECREASED 13 0.0003
798 TOOTH LOSS 6 0.0003
799 NERVOUS SYSTEM DISORDER 9 0.0003
800 DELIRIUM 10 0.0003
801 DERMATITIS 6 0.0003
802 DEMENTIA 8 0.0003
803 OFF LABEL USE 250 0.0003
804 HALLUCINATION, VISUAL 6 0.0003
805 DEPRESSED MOOD 15 0.0003
806 COLD SWEAT 5 0.0003
807 ASPARTATE AMINOTRANSFERASE INCREASED 15 0.0003
808 IMPAIRED WORK ABILITY 6 0.0003
809 INTENTIONAL DOSE OMISSION 8 0.0003
810 LEUKOPENIA 14 0.0003
811 THIRST 5 0.0003
812 PRURITUS GENERALISED 6 0.0003
813 SYNOVITIS 5 0.0003
814 TREMOR 46 0.0003
815 ALTERED STATE OF CONSCIOUSNESS 6 0.0003
816 COMPLETED SUICIDE 23 0.0003
817 DECREASED APPETITE 64 0.0003
818 PRODUCT DISPENSING ERROR 6 0.0003
819 PRODUCT PRESCRIBING ISSUE 6 0.0003
820 PELVIC PAIN 5 0.0003
821 CRYING 10 0.0003
822 NEEDLE ISSUE 8 0.0003
823 APATHY 4 0.0003
824 TREATMENT NONCOMPLIANCE 15 0.0003
825 JOINT SWELLING 33 0.0003
826 ERECTILE DYSFUNCTION 7 0.0003
827 CONFUSIONAL STATE 44 0.0003
828 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 7 0.0003
829 DIARRHOEA 175 0.0003
830 DRUG EFFECT LESS THAN EXPECTED 4 0.0003
831 SKIN DISORDER 9 0.0003
832 URINARY RETENTION 9 0.0003
833 ORAL PAIN 6 0.0003
834 HEPATIC FUNCTION ABNORMAL 10 0.0003
835 WEIGHT INCREASED 60 0.0003
836 BONE LOSS 4 0.0003
837 NASOPHARYNGITIS 49 0.0003
838 FLUSHING 27 0.0003
839 POLLAKIURIA 11 0.0003
840 SKIN IRRITATION 12 0.0003
841 INJECTION SITE PAIN 80 0.0003
842 PULMONARY FIBROSIS 5 0.0003
843 PALLOR 7 0.0003
844 MOOD ALTERED 7 0.0003
845 SWELLING 24 0.0003
846 RHEUMATOID ARTHRITIS 29 0.0003
847 INFLUENZA LIKE ILLNESS 21 0.0003
848 SYSTEMIC LUPUS ERYTHEMATOSUS 9 0.0003
849 ARRHYTHMIA 12 0.0003
850 PLATELET COUNT DECREASED 27 0.0003
851 MENTAL DISORDER 11 0.0003
852 PRESCRIBED UNDERDOSE 5 0.0003
853 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 12 0.0002
854 NO ADVERSE EVENT 45 0.0002
855 PRODUCT DOSE OMISSION IN ERROR 7 0.0002
856 MULTIPLE ORGAN DYSFUNCTION SYNDROME 7 0.0002
857 FLATULENCE 14 0.0002
858 MYOCARDIAL INFARCTION 43 0.0002
859 ALANINE AMINOTRANSFERASE INCREASED 15 0.0002
860 LUNG NEOPLASM MALIGNANT 10 0.0002
861 THROMBOCYTOPENIA 27 0.0002
862 PERITONITIS 5 0.0002
863 THERAPEUTIC RESPONSE SHORTENED 8 0.0002
864 SUICIDAL IDEATION 22 0.0002
865 PNEUMONIA ASPIRATION 6 0.0002
866 RHABDOMYOLYSIS 10 0.0002
867 INTENTIONAL DRUG MISUSE 5 0.0002
868 ASCITES 7 0.0002
869 PSYCHOTIC DISORDER 7 0.0002
870 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 8 0.0002
871 URINARY INCONTINENCE 7 0.0002
872 INCORRECT DOSE ADMINISTERED 53 0.0002
873 EXPOSURE VIA SKIN CONTACT 6 0.0002
874 AGITATION 17 0.0002
875 CONTRAINDICATED PRODUCT ADMINISTERED 7 0.0002
876 CONDITION AGGRAVATED 70 0.0002
877 DEAFNESS 6 0.0002
878 CLOSTRIDIUM DIFFICILE INFECTION 5 0.0002
879 DEVICE USE ISSUE 4 0.0002
880 DEPRESSED LEVEL OF CONSCIOUSNESS 9 0.0002
881 SLEEP DISORDER 16 0.0002
882 ACUTE RESPIRATORY DISTRESS SYNDROME 4 0.0002
883 DRUG ERUPTION 4 0.0002
884 SKIN EXFOLIATION 19 0.0002
885 CEREBROVASCULAR ACCIDENT 38 0.0002
886 CEREBRAL HAEMORRHAGE 8 0.0002
887 MALAISE 98 0.0002
888 ELECTROCARDIOGRAM QT PROLONGED 8 0.0002
889 PSORIATIC ARTHROPATHY 9 0.0002
890 PANIC ATTACK 8 0.0002
891 SKIN LESION 6 0.0002
892 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 12 0.0002
893 INTENTIONAL OVERDOSE 14 0.0002
894 WOUND 6 0.0002
895 THERAPEUTIC RESPONSE DECREASED 13 0.0002
896 INCORRECT DRUG ADMINISTRATION DURATION 6 0.0002
897 COLITIS 8 0.0002
898 ECZEMA 11 0.0002
899 RED BLOOD CELL COUNT DECREASED 6 0.0002
900 HERPES ZOSTER 12 0.0002
901 BLOOD CREATINE PHOSPHOKINASE INCREASED 6 0.0002
902 GENERAL PHYSICAL HEALTH DETERIORATION 24 0.0002
903 ERUCTATION 4 0.0002
904 MENTAL IMPAIRMENT 5 0.0002
905 UNDERDOSE 15 0.0002
906 DYSSTASIA 6 0.0002
907 HEPATIC ENZYME INCREASED 14 0.0002
908 MEMORY IMPAIRMENT 28 0.0002
909 INJECTION SITE URTICARIA 5 0.0002
910 INJECTION SITE REACTION 14 0.0002
911 BLOOD GLUCOSE INCREASED 38 0.0002
912 THERAPEUTIC RESPONSE UNEXPECTED 9 0.0002
913 HAEMATOCHEZIA 11 0.0002
914 PRODUCT DOSE OMISSION 13 0.0002
915 HEPATIC FAILURE 6 0.0002
916 UNEVALUABLE EVENT 15 0.0002
917 GLYCOSYLATED HAEMOGLOBIN INCREASED 5 0.0002
918 THERAPY INTERRUPTED 14 0.0002
919 TOXICITY TO VARIOUS AGENTS 33 0.0002
920 RASH GENERALISED 5 0.0002
921 PHARMACEUTICAL PRODUCT COMPLAINT 5 0.0002
922 C-REACTIVE PROTEIN INCREASED 7 0.0002
923 BONE DENSITY DECREASED 6 0.0002
924 ACCIDENTAL OVERDOSE 7 0.0002
925 INJECTION SITE MASS 7 0.0002
926 DISEASE RECURRENCE 9 0.0002
927 DRY SKIN 25 0.0002
928 DISEASE PROGRESSION 22 0.0002
929 PNEUMONITIS 5 0.0002
930 IRRITABILITY 11 0.0002
931 APPLICATION SITE PAIN 4 0.0002
932 GAMMA-GLUTAMYLTRANSFERASE INCREASED 4 0.0002
933 PLASMA CELL MYELOMA 7 0.0002
934 INJECTION SITE ERYTHEMA 22 0.0002
935 ABNORMAL BEHAVIOUR 7 0.0002
936 DRUG EXPOSURE DURING PREGNANCY 6 0.0002
937 ACCIDENTAL EXPOSURE TO PRODUCT 18 0.0002
938 DRUG DEPENDENCE 28 0.0002
939 NEUTROPHIL COUNT DECREASED 7 0.0002
940 RENAL DISORDER 8 0.0002
941 INTENTIONAL PRODUCT MISUSE 15 0.0002
942 INJECTION SITE SWELLING 13 0.0002
943 MOBILITY DECREASED 12 0.0002
944 WRONG TECHNIQUE IN DRUG USAGE PROCESS 6 0.0002
945 STOMATITIS 10 0.0002
946 INJECTION SITE PRURITUS 11 0.0002
947 INJECTION SITE RASH 5 0.0002
948 ALOPECIA 32 0.0002
949 ABASIA 4 0.0002
950 FEMUR FRACTURE 5 0.0002
951 DRY MOUTH 13 0.0002
952 AGGRESSION 8 0.0002
953 INTESTINAL OBSTRUCTION 6 0.0002
954 WHITE BLOOD CELL COUNT DECREASED 17 0.0002
955 ADVERSE DRUG REACTION 14 0.0002
956 MOVEMENT DISORDER 5 0.0002
957 NEUTROPENIA 21 0.0002
958 LOWER RESPIRATORY TRACT INFECTION 7 0.0002
959 NEOPLASM MALIGNANT 10 0.0001
960 BREAST CANCER FEMALE 4 0.0001
961 CARDIAC FAILURE 12 0.0001
962 MULTIPLE SCLEROSIS 7 0.0001
963 ADVERSE EVENT 13 0.0001
964 INCORRECT ROUTE OF DRUG ADMINISTRATION 5 0.0001
965 RESTLESSNESS 5 0.0001
966 ACNE 10 0.0001
967 ILL-DEFINED DISORDER 8 0.0001
968 DRUG EFFECT DECREASED 7 0.0001
969 DRUG WITHDRAWAL SYNDROME 11 0.0001
970 DEVICE BREAKAGE 5 0.0001
971 ANGER 4 0.0001
972 THERAPY CESSATION 6 0.0001
973 HYPOACUSIS 5 0.0001
974 DEVICE LEAKAGE 5 0.0001
975 VAGINAL HAEMORRHAGE 5 0.0001
976 LIVER DISORDER 5 0.0001
977 PRODUCT SUBSTITUTION ISSUE 6 0.0001
978 PRODUCT STORAGE ERROR 9 0.0001
979 DEATH 88 0.0001
980 MULTIPLE SCLEROSIS RELAPSE 7 0.0001
981 INJECTION SITE BRUISING 8 0.0001
982 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 7 0.0001
983 HOSPITALISATION 15 0.0001
984 OVERDOSE 21 0.0001
985 DEVICE DISLOCATION 4 0.0001
986 MATERNAL EXPOSURE DURING PREGNANCY 8 0.0001
987 DEVICE MALFUNCTION 6 0.0001
988 PSORIASIS 11 0.0001
989 SKIN BURNING SENSATION 6 0.0001
990 DRUG DOSE OMISSION 13 0.0001
991 MALIGNANT NEOPLASM PROGRESSION 8 0.0001
992 DEVICE ISSUE 7 0.0001
993 DISTURBANCE IN ATTENTION 4 0.0001
994 BREAST CANCER 6 0.0001
995 EXPOSURE DURING PREGNANCY 4 0.0001